UniProt ID | NR1H2_HUMAN | |
---|---|---|
UniProt AC | P55055 | |
Protein Name | Oxysterols receptor LXR-beta | |
Gene Name | NR1H2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 460 | |
Subcellular Localization | Nucleus . | |
Protein Description | Nuclear receptor that exhibits a ligand-dependent transcriptional activation activity. [PubMed: 25661920 Binds preferentially to double-stranded oligonucleotide direct repeats having the consensus half-site sequence 5'-AGGTCA-3' and 4-nt spacing (DR-4 Regulates cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8; DLDLR and LRP8. Interplays functionally with RORA for the regulation of genes involved in liver metabolism (By similarity Plays an anti-inflammatory role during the hepatic acute phase response by acting as a corepressor: inhibits the hepatic acute phase response by preventing dissociation of the N-Cor corepressor complex] | |
Protein Sequence | MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDWVIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGARRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQSQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSPTTSSL ------CCCCCCCCC | 45.05 | 25159151 | |
3 | Phosphorylation | -----MSSPTTSSLD -----CCCCCCCCCC | 25.60 | 25159151 | |
5 | Phosphorylation | ---MSSPTTSSLDTP ---CCCCCCCCCCCC | 41.06 | 23090842 | |
6 | Phosphorylation | --MSSPTTSSLDTPL --CCCCCCCCCCCCC | 21.50 | 25159151 | |
7 | Phosphorylation | -MSSPTTSSLDTPLP -CCCCCCCCCCCCCC | 31.23 | 23090842 | |
8 | Phosphorylation | MSSPTTSSLDTPLPG CCCCCCCCCCCCCCC | 28.33 | 23090842 | |
11 | Phosphorylation | PTTSSLDTPLPGNGP CCCCCCCCCCCCCCC | 31.83 | 23090842 | |
25 | Phosphorylation | PPQPGAPSSSPTVKE CCCCCCCCCCCCCCC | 42.80 | 25850435 | |
26 | Phosphorylation | PQPGAPSSSPTVKEE CCCCCCCCCCCCCCC | 39.00 | 25850435 | |
27 | Phosphorylation | QPGAPSSSPTVKEEG CCCCCCCCCCCCCCC | 29.00 | 25850435 | |
29 | Phosphorylation | GAPSSSPTVKEEGPE CCCCCCCCCCCCCCC | 46.27 | 23090842 | |
31 | Sumoylation | PSSSPTVKEEGPEPW CCCCCCCCCCCCCCC | 53.15 | - | |
126 | Methylation | GARRYACRGGGTCQM CCCCCCCCCCCCCHH | 38.32 | 30760333 | |
150 | Ubiquitination | QCRLRKCKEAGMREQ HHHHHHHHHHCCHHH | 54.34 | - | |
200 | Phosphorylation | SASGPGASPGGSEAG CCCCCCCCCCCCCCC | 29.96 | 24275569 | |
247 | Ubiquitination | RSFSDQPKVTPWPLG CCCCCCCCCCCCCCC | 53.78 | - | |
398 | Phosphorylation | VEALQQPYVEALLSY HHHHCCHHHHHHHHH | 13.44 | 28450419 | |
404 | Phosphorylation | PYVEALLSYTRIKRP HHHHHHHHHHCCCCH | 25.88 | 28450419 | |
406 | Phosphorylation | VEALLSYTRIKRPQD HHHHHHHHCCCCHHH | 23.65 | 28450419 | |
409 | Sumoylation | LLSYTRIKRPQDQLR HHHHHCCCCHHHHCC | 55.52 | - | |
409 | Sumoylation | LLSYTRIKRPQDQLR HHHHHCCCCHHHHCC | 55.52 | 20159957 | |
426 | Phosphorylation | RMLMKLVSLRTLSSV HHHHHHHHHHHHHHC | 23.67 | 24719451 | |
447 | Sumoylation | ALRLQDKKLPPLLSE HHHHCCCCCCCHHHH | 74.62 | - | |
447 | Sumoylation | ALRLQDKKLPPLLSE HHHHCCCCCCCHHHH | 74.62 | 20159957 | |
447 | Ubiquitination | ALRLQDKKLPPLLSE HHHHCCCCCCCHHHH | 74.62 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
426 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NR1H2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...